Caligan Partners

Caligan Partners as of June 30, 2024

Portfolio Holdings for Caligan Partners

Caligan Partners holds 13 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Liquidia Corporation Com New (LQDA) 29.0 $124M 10M 12.00
Alimera Sciences Com New 21.9 $94M 17M 5.56
Anika Therapeutics (ANIK) 8.5 $36M 1.4M 25.33
Exelixis (EXEL) 8.0 $34M 1.5M 22.47
BioCryst Pharmaceuticals (BCRX) 6.6 $28M 4.6M 6.18
Verona Pharma Sponsored Ads (VRNA) 6.2 $27M 1.8M 14.46
Evolus (EOLS) 5.5 $24M 2.2M 10.85
Agios Pharmaceuticals (AGIO) 5.2 $22M 515k 43.12
Enanta Pharmaceuticals (ENTA) 3.2 $14M 1.0M 12.97
Mineralys Therapeutics (MLYS) 2.0 $8.7M 746k 11.70
Y Mabs Therapeutics (YMAB) 1.6 $7.0M 582k 12.08
I Mab Sponsored Ads (IMAB) 1.3 $5.6M 3.4M 1.67
Outlook Therapeutics (OTLK) 0.9 $3.7M 500k 7.38